Pacific Biosciences Of California | PACB - 净收入



金融业
股票价格
USD
资产
USD 782.37M
现金及等价物
USD 56.27M
销售成本
USD 28.9M
流动资产
USD 369.52M
流动负债
USD 65.36M
债务
USD 892.24M
股息收益率
0
EBIT
USD -53.19M
EBITDA
USD -35.4M
员工
796
EPS每股收益
USD -0.17
股本和储备
USD 2.37M
销售毛利
USD 15.74M
债务利息支出
USD 1.74M
贷款资金
USD 645.38M
市值
USD 431.4M
净收入
USD -40.37M
营业费用
USD 97.83M
营业利润
USD -53.19M
普通股股本
USD 301.96M
税前利润
USD -40.17M
销售收入
USD 44.65M
销售和管理费用
USD 37.24M
股票
USD 51.02M
贸易债权人
USD 13.61M
应收帐款人
USD 35.45M


净收入 更改 日
Agilent USD 339M 34M 2026-03
Bruker USD 3.5M 22.5M 2026-03
Danaher USD 1.03B 168M 2026-03
General Electric Aerospace USD 1.9B 637M 2026-03
Illumina USD 134M 200M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quidel USD -91.8M 38.9M 2026-03
Revvity USD 40.72M 57.65M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Standard Biotools USD 127.07M 107.78M 2026-03
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Waters USD -72M 297.21M 2026-03